Mach7 Technologies Limited

M7T

AU000000M7T0

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 02:10:51 2024-07-17 EDT			5-day change	1st Jan Change
0.6 ^AUD	+0.84%		-2.44%	-24.05%

06-19	Mach7 Technologies Secures Renewal for Imaging Platform, Diagnostic Viewer	MT
06-13	NANO-X IMAGING LTD Appoints Michael Jackman as Member of the Board, Effective as of July 1, 2024	CI

Mach7 Technologies Limited announced that it has received AUD 0.26 million in funding

January 11, 2018

Mach7 Technologies Limited announced a private placement of 994,582 common shares at a price of AUD 0.257 for gross proceeds of AUD 255,607.574 on January 12, 2018.

Latest news about Mach7 Technologies Limited

Mach7 Technologies Secures Renewal for Imaging Platform, Diagnostic Viewer	06-18	MT
NANO-X IMAGING LTD Appoints Michael Jackman as Member of the Board, Effective as of July 1, 2024	06-13	CI
Mach7 Technologies Posts 20% Annual Recurring Revenue Increase to AU$22.3 Million for March Quarter	04-24	MT
Transcript : Mach7 Technologies Limited, Q3 2024 Earnings Call, Apr 24, 2024	04-23
Mach7 Technologies Limited(ASX:M7T) added to S&P/ASX All Ordinaries Index	03-17	CI
Mach7 Technologies Extends Enterprise Imaging Platform Agreement with Penn State Health	03-04	MT
Mach7 Technologies Loss Widens in Fiscal H1 as Revenue Slides 19%	02-28	MT
Transcript : Mach7 Technologies Limited, H2 2023 Earnings Call, Feb 29, 2024	02-28
Mach7 Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
Transcript : Mach7 Technologies Limited, Q2 2024 Earnings Call, Jan 31, 2024	01-30
Mach7 Technologies Limited Revises Revenue Guidance for the Year 2024	01-23	CI
Mach7 Technologies Signs Five-Year Subscription Agreement with Sentara Healthcare; Shares Jump 5%	12-13	MT
Mach7 Technologies Limited Appoints Rebecca Thompson as Director	11-15	CI
Transcript : Mach7 Technologies Limited - Shareholder/Analyst Call	11-15
Transcript : Mach7 Technologies Limited, Q1 2024 Earnings Call, Oct 31, 2023	23-10-30
Mach7 Technologies Appoints Chair	23-10-25	MT
Transcript : Mach7 Technologies Limited - Analyst/Investor Day	23-10-08
HAHK Extends Contract With Mach7 Technologies	23-09-28	MT
Mach7 Technologies Limited Announces Board Changes, Effective 16 November 2023	23-09-21	CI
Mach7 Technologies Announces That it Has Selected as a Solution Provider for Veterans Health Administration's National Teleradiology Program Nextgen Pacs	23-09-06	CI
Transcript : Mach7 Technologies Limited, 2023 Earnings Call, Aug 31, 2023	23-08-30
Mach7 Technologies Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Mach7 Technologies' Chairman to Retire in November; Shares Rise 3%	23-08-09	MT
Mach7 Technologies Limited Announces the Retirement of David Chambers as Chair and Non-Executive Director, Effective 16 November 2023	23-08-09	CI
Transcript : Mach7 Technologies Limited, Q4 2023 Earnings Call, Jul 31, 2023	23-07-30

Chart Mach7 Technologies Limited

Duration

Period

More charts

Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The principal activity of the Company is the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7âs Enterprise Data Management solution consists of a Vendor Neutral Archive (VNA) and data administration tools, which allow for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the cloud. Enterprise Diagnostic Viewing offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. It offers its solutions across North America, Asia Pacific, and the Middle East region.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-29 - June 2024 Sales and Revenue Release - Activities Report

More about the company

Income Statement Evolution

More financial data

Ratings for Mach7 Technologies Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.595 AUD

Average target price

1.242 AUD

Spread / Average Target

+108.76%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
MACH7 TECHNOLOGIES LIMITED	-24.05%	96.5M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-23.23%	11.87B
IRAY TECHNOLOGY COMPANY LIMITED	-54.41%	2.08B
SONOSCAPE MEDICAL CORP.	-30.06%	1.96B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-29.86%	1.16B
NANO-X IMAGING LTD.	+49.45%	550M
GUERBET	+105.13%	543M
DETECTION TECHNOLOGY OYJ	+20.07%	267M
DRTECH CORPORATION	-3.05%	220M
VIEWORKS CO., LTD.	+1.30%	181M

Medical Imaging Systems